|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Cash Flows from Operating Activities: | |
| Net income (loss) | |
| Adjustments to reconcile net income to net cash used in operating activities: | |
| Interest earned on investments held in Trust Account | |
| Payment of operation costs through IPO Promissory Note | |
| Changes in operating assets and liabilities: | |
| Prepaid expenses | |
| Long-term prepaid insurance | |
| Accounts payable and accrued expenses | |
| Net cash used in operating activities | |
| Cash Flows from Investing Activities: | |
| Investment of cash into Trust Account | |
| Net cash used in investing activities | |
| Cash Flows from Financing Activities: | |
| Proceeds from sale of Units, net of underwriting discounts paid | |
| Proceeds from sale of Private Placement Units | |
| Repayment of IPO Promissory Note - related party | |
| Payment of offering costs | |
| Net cash provided by financing activities | |
| Net change in cash | |
| Cash and cash equivalents, end of the period | |
| Noncash investing and financing activities: | |
| Deferred offering costs paid through promissory note – related party | |
| Offering costs included in accrued offering costs | |
| Deferred underwriting fee payable |
Loading...
